A milk protein lactoferrin enhances human T cell leukemia virus type I and suppresses HIV-1 infection.
about
Tenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milkMother-to-Child Transmission of HTLV-1 Epidemiological Aspects, Mechanisms and Determinants of Mother-to-Child TransmissionAdvances in HIV microbicide developmentGlycoprotein expression in human milk during lactation.Hiv-specific secretory IgA in breast milk of HIV-positive mothers is not associated with protection against HIV transmission among breast-fed infants.Induction of lactoferrin gene expression in myeloid or mammary gland cells by human T-cell leukemia virus type 1 (HTLV-1) tax: implications for milk-borne transmission of HTLV-1.Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluidsThe therapeutic potential of lactoferrin.The Presence and Anti-HIV-1 Function of Tenascin C in Breast Milk and Genital Fluids.Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection.Human beta-defensins 2 and -3 cointernalize with human immunodeficiency virus via heparan sulfate proteoglycans and reduce infectivity of intracellular virions in tonsil epithelial cellsAlternative modified infant-feeding practices to prevent postnatal transmission of human immunodeficiency virus type 1 through breast milk: past, present, and future.[Vertical transmission of HTLV-1 in Peru]Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast Milk.Mucosal innate immunity as a determinant of HIV susceptibility.Seminal fluid enhances replication of human T-cell leukemia virus type 1: implications for sexual transmission.HIV infection in the female genital tract: discrete influence of the local mucosal microenvironment.HIV-1 infection in the female reproductive tract: role of interactions between HIV-1 and genital epithelial cells.Heat Shock Enhances the Expression of the Human T Cell Leukemia Virus Type-I (HTLV-I) Trans-Activator (Tax) Antigen in Human HTLV-I Infected Primary and Cultured T Cells.Role of CXC chemokine receptor type 4 as a lactoferrin receptor.Route of primary HTLV-1 infection regulates HTLV-1 distribution in reservoir organs of infected mice.Adenoviruses use lactoferrin as a bridge for CAR-independent binding to and infection of epithelial cells.Cell-type-dependent effect of transforming growth factor beta, a major cytokine in breast milk, on human immunodeficiency virus type 1 infection of mammary epithelial MCF-7 cells or macrophages.Identification of anti-inflammatory drugs according to their capacity to suppress type-1 and type-2 T cell profiles.Transforming growth factor-beta enhances human T-cell leukemia virus type I infection.Effects of bovine lactoferrin on in vitro replication of feline herpesvirus.
P2860
Q24598653-56428A68-438A-496A-8391-1075C5C28D53Q26768624-7866A10E-38B3-4F08-8219-C47AFF3E6B46Q26852858-2905C2F3-2E22-4904-A4E9-E1E0C39D632DQ30388479-AF5A54BB-EA2D-4D63-B168-EA1D97C4E03FQ33609816-6D71E66B-89CE-4A4D-893A-678155FA3518Q34717839-04DF8E06-D645-4D62-B790-43F51F1AE0D0Q35075174-41916F44-A029-45B6-98BC-9C22799F5942Q35117090-562AC0D5-0C49-4545-A837-2C35F90D1922Q36018536-1F58F932-E579-4E1B-9AD4-1E66E1920FDDQ36095139-CFD6D6E7-E429-4D7D-A988-B637D8F5A756Q36373244-1014DB8E-1B16-4FB7-82E7-0163FEF58179Q36391604-AEE9D28A-4A38-4981-A4E8-AC91D41F9390Q36433194-9BAFE095-4FB3-4509-AD21-89D9CE4DB27AQ36878930-21922154-261B-4396-9DEE-AA67C779122BQ37043682-9099E9C1-8ACF-4634-AB37-CF7AE6272D24Q37596955-9CC0C011-CFC1-426C-9EA2-FFF1492C32BAQ37729252-64AC9DE1-7FE0-416E-BEC3-DFC1EE9ACBCEQ37827574-7C7E920E-3430-4192-B472-DFF98C992743Q38758402-5ECE2C98-CCDA-4AE4-8DD5-B3794E073829Q39506215-08574AC4-602B-4F01-96F3-E19CF245DF94Q39508913-70FFAF66-4AA9-4967-9A69-25665A2C99B3Q40213253-01231A64-75B9-4208-962B-EA3AE058C6BAQ40274771-8F03EF1C-0733-4880-90AE-06415AF78816Q45233075-3442BBB1-6653-41BE-BA07-D22E5F8D1B80Q45731770-4D2EC845-7252-46ED-8F14-24864A315010Q45942473-D3E66F55-7868-48A9-B9A2-01F09ADBB4FF
P2860
A milk protein lactoferrin enhances human T cell leukemia virus type I and suppresses HIV-1 infection.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A milk protein lactoferrin enh ...... nd suppresses HIV-1 infection.
@ast
A milk protein lactoferrin enh ...... nd suppresses HIV-1 infection.
@en
A milk protein lactoferrin enh ...... nd suppresses HIV-1 infection.
@nl
type
label
A milk protein lactoferrin enh ...... nd suppresses HIV-1 infection.
@ast
A milk protein lactoferrin enh ...... nd suppresses HIV-1 infection.
@en
A milk protein lactoferrin enh ...... nd suppresses HIV-1 infection.
@nl
prefLabel
A milk protein lactoferrin enh ...... nd suppresses HIV-1 infection.
@ast
A milk protein lactoferrin enh ...... nd suppresses HIV-1 infection.
@en
A milk protein lactoferrin enh ...... nd suppresses HIV-1 infection.
@nl
P1476
A milk protein lactoferrin enh ...... nd suppresses HIV-1 infection.
@en
P2093
Moriuchi H
Moriuchi M
P304
P356
10.4049/JIMMUNOL.166.6.4231
P407
P577
2001-03-01T00:00:00Z